Versatile PLGA-Based Drug Delivery Systems for Tumor Immunotherapy

Area of Science:

• Biomaterials Science
• Immunology
• Oncology

Background:

• Tumor immunotherapy leverages the immune system to combat cancer, offering a revolutionary treatment approach.
• Poly (lactic-co-glycolic acid) (PLGA) copolymers are increasingly recognized for their biocompatibility, biodegradability, and adaptable drug delivery capabilities in cancer therapy.

Purpose of the Study:

• To review the fundamental properties of PLGA materials.
• To summarize PLGA-based systems for controlled drug release and their delivery applications in cancer immunotherapy.
• To highlight recent advancements in PLGA systems for enhancing antitumor immune responses.

Main Methods:

• Review of existing literature on PLGA materials and their applications in tumor immunotherapy.
• Analysis of PLGA system properties, including size, shape, and surface modifications.
• Categorization of PLGA applications in tumor vaccines, immunogenic cell death, tumor microenvironment modulation, and combination therapies.

Main Results:

• PLGA systems can be tailored in size, shape, and surface properties to meet diverse immunotherapy needs.
• PLGA delivery systems have demonstrated efficacy in enhancing antitumor immune responses through various strategies.
• Key applications include tumor vaccines, promoting immunogenic cell death, modulating the tumor microenvironment, and combination immunotherapies.

Conclusions:

• PLGA copolymers are highly promising materials for advancing tumor immunotherapy due to their tunable properties and versatile delivery applications.
• Further research and clinical translation of PLGA-based systems hold significant potential for improving cancer treatment outcomes.
• PLGA's adaptability makes it a key player in developing next-generation cancer immunotherapies.